KALYONCU, U. Et Al. 2021. TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA. EULAR Congress of Rheumatology , (Switzerland), 69.

KALYONCU, U., BİLGİN, E., ERDEN, A., Satiş, H., TUFAN, A., TEKGÖZ, E., ... ATEŞ, A.(2021). TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA . EULAR Congress of Rheumatology (pp.69). , Switzerland

KALYONCU, UMUT Et Al. "TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA," EULAR Congress of Rheumatology, Switzerland, 2021

KALYONCU, UMUT Et Al. "TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA." EULAR Congress of Rheumatology , Switzerland, pp.69, 2021

KALYONCU, U. Et Al. (2021) . "TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA." EULAR Congress of Rheumatology , Switzerland, p.69.

@conferencepaper{conferencepaper, author={UMUT KALYONCU Et Al. }, title={TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA}, congress name={EULAR Congress of Rheumatology}, city={}, country={Switzerland}, year={2021}, pages={69} }